Strategic Analysis of World Emerging Neurological Therapeutics Markets
Strategic Analysis of World Emerging Neurological Therapeutics Markets
RELEASE DATE
28-Jul-2004
28-Jul-2004
REGION
Global
Global
Research Code: F057-01-00-00-00
SKU: HC01403-GL-MR_05829
$3,950.00
In stock
SKU
HC01403-GL-MR_05829
Description
This research service evaluates the emerging neurlogical therapeutics markets for Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Factors affecting market growth, existing market trends, pipeline trends, challenges, strategic product profiles, revenue analysis, and awards are presented for each therapeutic area.
Table of Contents
Overview
- Introduction
- Disclaimer
- Certification
- Research Scope and Methodology
- Study Objectives
- Market Segmentation by Geographical Region
- Market Segmentation by Disease
Competitive Landscape
- Major Market Participants
- Growth Analysis by Neurological Market
- Phase III Products
- Phase I and II Products A
- Phase I and II Products B
- Phase I and II Products C
Alzheimer's Disease
- Prevalence by Geographical Region
- Current Treatments and Market Participants
- Revenue Growth Analysis
- Alzheimer's Disease Market by Geographical Region
- Revenue Growth by Geographical Region
- Market Share Analysis by Company
- Market Challenges
- Market Drivers
- Market Restraints
- Clinical Development
- Executive Quote (Alzheimer's Association)
- Pipeline Analysis
- Executive Quote (Axoynx)
- Product Analysis: Phenserine
Parkinson's Disease
- Disease Overview
- Market Overview
- First-Line Therapy
- Second-Line Therapy
- Prevalence by Geographical Region
- Revenue Growth Analysis
- Parkinson's Disease Market by Geographical Region
- Market Share Analysis by Product
- Market Challenges
- Market Drivers
- Market Restraints
- Clinical Development
- Pipeline Analysis
- Executive Quote (Teva Neurosciences)
- Product Analysis: Rasagaline
Multiple Sclerosis
- Market Overview
- Prevalence by Geographical Region
- Revenue Growth Analysis
- Multiple Sclerosis Market by Geographical Region
- Revenue Growth by Geographical Region
- Market Share Analysis by Product
- Market Challenges
- Market Drivers
- Market Restraints
- Clinical Development
- Executive Quote (National Multiple Sclerosis Society)
- Pipeline Analysis
- Executive Quote (The Immune Response Corporation)
- Executive Quote (Berlex)
- Executive Quote (Elan Pharmaceuticals)
- Product Analysis: Antegren
Decision Support Databases
- Number of Alzheimer's Patients
- Psychiatrists
- Neurologists
- Physicians
- Total Population 65 and Above
Frost & Sullivan Awards
- Introduction
- Entrepreneurial Company of the Year Award
- Industry Innovation and Advancement of the Year Award
- Technology Excellence Award
- Product Innovation Award
Frost & Sullivan
- Healthcare Team
- Our Capabilities
- Key Advantages
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Service Platform
Popular Topics
This research service evaluates the emerging neurlogical therapeutics markets for Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Factors affecting market growth, existing market trends, pipeline trends, challenges, strategic product profiles, revenue analysis, and awards are presented for each therapeutic area.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | F057-01-00-00-00 |
Is Prebook | No |